TPI-120

· Adello Biologics, LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TPI-120, covering 2018-07-03 to 2018-07-05. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Immunogenicity Study Comparing TPI-120 to Neulasta® in Healthy Adult Subjects [Phase 1]